BHPI

BHPI

CAT N°: 17750
Price:

From 85.00 72.25

BHPI is an antagonist of estrogen receptor ? (ER?) that blocks 17?-estradiol-induced proliferation of drug-resistant breast, endometrial, and ovarian cancer cell lines at concentrations ranging from 10 to 1,000 nM.{28679} It is effective in vivo, driving tumor regression in mice bearing MCF-7 xenografts at a dose of 15 mg/kg daily.{28679} BHPI specifically inhibits ER?-dependent gene expression and protein synthesis by activating the unfolded protein response in cells.{28679}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-7-methyl-2H-indol-2-one
  • Correlated keywords
    • 3,3-bis (p-hydroxyphenyl)-7-methyl-2-indolinone steroid receptor antagonist endocrinology nuclear gene regulation cancer biochemical ER? ERa estrogen ? a ER
  • Product Overview:
    BHPI is an antagonist of estrogen receptor ? (ER?) that blocks 17?-estradiol-induced proliferation of drug-resistant breast, endometrial, and ovarian cancer cell lines at concentrations ranging from 10 to 1,000 nM.{28679} It is effective in vivo, driving tumor regression in mice bearing MCF-7 xenografts at a dose of 15 mg/kg daily.{28679} BHPI specifically inhibits ER?-dependent gene expression and protein synthesis by activating the unfolded protein response in cells.{28679}

We also advise you